NI, do you publish a newsletter? I just got an excerpt from a newsletter, Neuro Investment, from my broker. CNSI is mentioned as one of the promising companies that will bring the next wave of developments in this area. Also, there was an attached article regarding Genesis Merchant Group Securities upgrading CNSI from buy to stong buy. Paul Boni "...said the upgrade was based on recent price weakness. He said the outlook remains poitive for the company's drug Cerestat, which was developed to treat head trauma and stroke...12-month price target of 35. Positive clinical results for Cerestat would justify a share price of 50, he said."
Also, for my own curiosity, do you own any CNSI? And finally, do you have a medical background? In my case, I bought into CNSI first, on a recommendation, and then started doing the research. The more I find out about CNSI, the better I feel about their prospects but I don't have a medical educational and vocational background that I can bring to bear on this. Thanks! |
